These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35854087)

  • 21. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants.
    Chan CS; Chiu M; Ariyapadi S; Brown LS; Burchfield P; Simcik V; Garcia K; Mazioniene K; Jaleel MA; Wyckoff MH; Kapadia VS; Kakkilaya V
    Pediatr Res; 2024 May; 95(6):1603-1610. PubMed ID: 38097721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.
    Mansouri M; Servatyari K; Rahmani K; Sheikhahmadi S; Hemmatpour S; Eskandarifar A; Rahimzadeh M
    J Neonatal Perinatal Med; 2024; 17(2):233-239. PubMed ID: 38759030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thin-catheter Surfactant Application for Respiratory Distress Syndrome in Spontaneously Breathing Preterm Infants: A Meta-analysis of Randomized Clinical Trials.
    Kesler H; Lohmeier K; Hoehn T; Kribs A; Peinemann F
    Curr Pediatr Rev; 2022; 18(4):286-300. PubMed ID: 35379135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks--Short and Long-term Outcomes.
    Teig N; Weitkämper A; Rothermel J; Bigge N; Lilienthal E; Rossler L; Hamelmann E
    Z Geburtshilfe Neonatol; 2015 Dec; 219(6):266-73. PubMed ID: 26550923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center.
    Bao Y; Zhang G; Wu M; Ma L; Zhu J
    BMC Pediatr; 2015 Mar; 15():21. PubMed ID: 25885964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity.
    Klebermass-Schrehof K; Wald M; Schwindt J; Grill A; Prusa AR; Haiden N; Hayde M; Waldhoer T; Fuiko R; Berger A
    Neonatology; 2013; 103(4):252-8. PubMed ID: 23446061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
    Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
    Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Adherence to Surfactant Best Practice Uses With Clinical Outcomes Among Neonates in Sweden.
    Challis P; Nydert P; Håkansson S; Norman M
    JAMA Netw Open; 2021 May; 4(5):e217269. PubMed ID: 33950208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
    BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of less invasive surfactant administration (LISA), impact on diagnostic and therapeutic procedures in early life: a historical cohort study.
    Bugter IAL; Janssen LCE; Dieleman J; Kramer BW; Andriessen P; Niemarkt HJ
    BMC Pediatr; 2020 Sep; 20(1):421. PubMed ID: 32883280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early surfactant and non-invasive ventilation versus intubation and surfactant: a propensity score-matched national study.
    Reigstad H; Hufthammer KO; Rønnestad AE; Klingenberg C; Stensvold HJ; Markestad T;
    BMJ Paediatr Open; 2022 Jul; 6(1):. PubMed ID: 36053649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 38. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory distress syndrome in preterm infants: possible impact of surfactant application techniques.
    Krajewski P; Pomianek T; Truszkowski K; Wieckowska K; Gorska M; Wielgos M
    Ginekol Pol; 2022; 93(9):750-755. PubMed ID: 35106747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants.
    Cucerea M; Moscalu M; Moldovan E; Santa R; Gall Z; Suciu LM; Simon M
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.